Skip to main content
Top

04-01-2025 | Hyperemesis Gravidarum | Narrative review

Gastrointestinal symptoms and disorders of gut-brain interaction in pregnancy

Authors: Abhinav Jain, Shraddha Ramchandani, Shobna Bhatia

Published in: Indian Journal of Gastroenterology

Login to get access

Abstract

Gastrointestinal (GI) symptoms occur frequently in pregnant women, resulting in poor quality of life. These patients frequently require co-management with the obstetrician and a physician/GI specialist. The causation is complex and multifactorial. It is a result of a combination of maternal changes in pregnancy and feto-placental hormonal effects on the GI tract (the feto-placental-gut axis). Additional factors such as the gut-brain interaction, genetics, immune response and effects of maternal supplements during pregnancy also contribute to the causation of symptoms. The most common of these symptoms include nausea and vomiting followed by heartburn. The common lower GI symptoms include constipation and hemorrhoids. Irritable bowel syndrome (IBS) is also common in a pregnant patient. But there is a paucity of literature and high-quality studies concerning the management of IBS. This review addresses the pathophysiology and clinical and laboratory evaluation of the common upper GI and lower GI symptoms and their management. A majority of symptoms are mild and lifestyle modifications with non-pharmacological measures should be the first-line management, whereas drugs should be used judiciously in case of non-response or severe symptoms. The nutritional status of the mother and the fetus needs close monitoring. Drugs that are routinely used in pregnancy are discussed with regard to the safety of the mother and the fetus. GI endoscopy may be needed in select patients and the indications for endoscopy and colonoscopy in pregnancy along with special pregnancy-related precautions are discussed. Most symptoms improve to pre-pregnancy state after delivery.
Appendix
Available only for authorised users
Literature
2.
go back to reference Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. J Pharmacokinet Pharmacodyn. 2020;47:271–85.PubMedPubMedCentralCrossRef Kazma JM, van den Anker J, Allegaert K, Dallmann A, Ahmadzia HK. Anatomical and physiological alterations of pregnancy. J Pharmacokinet Pharmacodyn. 2020;47:271–85.PubMedPubMedCentralCrossRef
3.
go back to reference Riezzo G, Pezzolla F, Darconza G, Giorgio I. Gastric myoelectrical activity in the first trimester of pregnancy: a cutaneous electrogastrographic study. Am J Gastroenterol. 1992;87:702–7.PubMed Riezzo G, Pezzolla F, Darconza G, Giorgio I. Gastric myoelectrical activity in the first trimester of pregnancy: a cutaneous electrogastrographic study. Am J Gastroenterol. 1992;87:702–7.PubMed
4.
go back to reference Christofides ND, Ghatei MA, Bloom SR, Borberg C, Gillmer MD. Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed). 1982;285:1453–4.PubMedCrossRef Christofides ND, Ghatei MA, Bloom SR, Borberg C, Gillmer MD. Decreased plasma motilin concentrations in pregnancy. Br Med J (Clin Res Ed). 1982;285:1453–4.PubMedCrossRef
5.
go back to reference Lawson M, Kern F, Everson GT. Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology. 1985;89:996–9.PubMedCrossRef Lawson M, Kern F, Everson GT. Gastrointestinal transit time in human pregnancy: prolongation in the second and third trimesters followed by postpartum normalization. Gastroenterology. 1985;89:996–9.PubMedCrossRef
6.
go back to reference Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? Ann Gastroenterol. 2018;31:385–94.PubMedPubMedCentral Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? Ann Gastroenterol. 2018;31:385–94.PubMedPubMedCentral
8.
go back to reference Korevaar TIM, Steegers EAP, de Rijke YB, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30:1057–66.PubMedPubMedCentralCrossRef Korevaar TIM, Steegers EAP, de Rijke YB, et al. Reference ranges and determinants of total hCG levels during pregnancy: the Generation R Study. Eur J Epidemiol. 2015;30:1057–66.PubMedPubMedCentralCrossRef
9.
go back to reference Dypvik J, Pereira AL, Tanbo TG, Eskild A. Maternal human chorionic gonadotrophin concentrations in very early pregnancy and risk of hyperemesis gravidarum: a retrospective cohort study of 4372 pregnancies after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2018;221:12–6.PubMedCrossRef Dypvik J, Pereira AL, Tanbo TG, Eskild A. Maternal human chorionic gonadotrophin concentrations in very early pregnancy and risk of hyperemesis gravidarum: a retrospective cohort study of 4372 pregnancies after in vitro fertilization. Eur J Obstet Gynecol Reprod Biol. 2018;221:12–6.PubMedCrossRef
10.
go back to reference Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy - what’s new? Auton Neurosci. 2017;202:62–72.PubMedCrossRef Bustos M, Venkataramanan R, Caritis S. Nausea and vomiting of pregnancy - what’s new? Auton Neurosci. 2017;202:62–72.PubMedCrossRef
13.
go back to reference North RA, Whitehead R, Larkins RG. Stimulation by human chorionic gonadotropin of prostaglandin synthesis by early human placental tissue. J Clin Endocrinol Metab. 1991;73:60–70.PubMedCrossRef North RA, Whitehead R, Larkins RG. Stimulation by human chorionic gonadotropin of prostaglandin synthesis by early human placental tissue. J Clin Endocrinol Metab. 1991;73:60–70.PubMedCrossRef
14.
go back to reference Aka N, Atalay S, Sayharman S, Kiliç D, Köse G, Küçüközkan T. Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol. 2006;46:274–7.PubMedCrossRef Aka N, Atalay S, Sayharman S, Kiliç D, Köse G, Küçüközkan T. Leptin and leptin receptor levels in pregnant women with hyperemesis gravidarum. Aust N Z J Obstet Gynaecol. 2006;46:274–7.PubMedCrossRef
15.
go back to reference Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med. 2009;6:152–67.PubMedPubMedCentralCrossRef Heitkemper MM, Chang L. Do fluctuations in ovarian hormones affect gastrointestinal symptoms in women with irritable bowel syndrome? Gend Med. 2009;6:152–67.PubMedPubMedCentralCrossRef
17.
go back to reference Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit. 2004;10:RA55-62.PubMed Mulak A, Bonaz B. Irritable bowel syndrome: a model of the brain-gut interactions. Med Sci Monit. 2004;10:RA55-62.PubMed
18.
go back to reference Kern F Jr, Everson GT, DeMark B, et al. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med. 1982;99:798–805.PubMed Kern F Jr, Everson GT, DeMark B, et al. Biliary lipids, bile acids, and gallbladder function in the human female: effects of contraceptive steroids. J Lab Clin Med. 1982;99:798–805.PubMed
19.
go back to reference Cheikh Ismail L, Bishop DC, Pang R, et al. Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study. BMJ. 2016;352: i555.PubMedPubMedCentralCrossRef Cheikh Ismail L, Bishop DC, Pang R, et al. Gestational weight gain standards based on women enrolled in the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project: a prospective longitudinal cohort study. BMJ. 2016;352: i555.PubMedPubMedCentralCrossRef
20.
go back to reference Bradley CS, Kennedy CM, Turcea AM, Rao SS, Nygaard IE. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol. 2007;110:1351–7.PubMedCrossRef Bradley CS, Kennedy CM, Turcea AM, Rao SS, Nygaard IE. Constipation in pregnancy: prevalence, symptoms, and risk factors. Obstet Gynecol. 2007;110:1351–7.PubMedCrossRef
21.
go back to reference Gill SK, Maltepe C, Koren G. The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy. J Obstet Gynaecol (Lahore). 2009;29:13–6.CrossRef Gill SK, Maltepe C, Koren G. The effectiveness of discontinuing iron-containing prenatal multivitamins on reducing the severity of nausea and vomiting of pregnancy. J Obstet Gynaecol (Lahore). 2009;29:13–6.CrossRef
22.
go back to reference Body C, Christie JA. Gastrointestinal diseases in pregnancy. Nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. Gastroenterol Clin North Am. 2016;45:267–83.PubMedCrossRef Body C, Christie JA. Gastrointestinal diseases in pregnancy. Nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. Gastroenterol Clin North Am. 2016;45:267–83.PubMedCrossRef
23.
go back to reference Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182:931–7.PubMedCrossRef Lacroix R, Eason E, Melzack R. Nausea and vomiting during pregnancy: a prospective study of its frequency, intensity, and patterns of change. Am J Obstet Gynecol. 2000;182:931–7.PubMedCrossRef
24.
go back to reference Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20:e171–83.PubMed Einarson TR, Piwko C, Koren G. Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis. J Popul Ther Clin Pharmacol. 2013;20:e171–83.PubMed
25.
go back to reference Jansen LAW, Koot MH, Van’tHooft J, et al. The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021;266:15–22.PubMedCrossRef Jansen LAW, Koot MH, Van’tHooft J, et al. The windsor definition for hyperemesis gravidarum: a multistakeholder international consensus definition. Eur J Obstet Gynecol Reprod Biol. 2021;266:15–22.PubMedCrossRef
26.
go back to reference Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum (Green-top Guideline No. 69). BJOG. 2024;131:e1–30.PubMedCrossRef Nelson-Piercy C, Dean C, Shehmar M, et al. The management of nausea and vomiting in pregnancy and hyperemesis gravidarum (Green-top Guideline No. 69). BJOG. 2024;131:e1–30.PubMedCrossRef
27.
go back to reference Koren G, Piwko C, Ahn E, et al. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol (Lahore). 2005;25:241–4.CrossRef Koren G, Piwko C, Ahn E, et al. Validation studies of the Pregnancy Unique-Quantification of Emesis (PUQE) scores. J Obstet Gynaecol (Lahore). 2005;25:241–4.CrossRef
28.
go back to reference MacGibbon KW, Kim S, Mullin PM, Fejzo MS. HyperEmesis Level Prediction (HELP Score) identifies patients with indicators of severe disease: a validation study. Geburtshilfe Frauenheilkd. 2021;81:90–8.PubMedPubMedCentralCrossRef MacGibbon KW, Kim S, Mullin PM, Fejzo MS. HyperEmesis Level Prediction (HELP Score) identifies patients with indicators of severe disease: a validation study. Geburtshilfe Frauenheilkd. 2021;81:90–8.PubMedPubMedCentralCrossRef
29.
go back to reference Elkins JR, Oxentenko AS, Nguyen LAB. Hyperemesis gravidarum and nutritional support. Am J Gastroenterol. 2022;117(10S):2–9.PubMedCrossRef Elkins JR, Oxentenko AS, Nguyen LAB. Hyperemesis gravidarum and nutritional support. Am J Gastroenterol. 2022;117(10S):2–9.PubMedCrossRef
31.
go back to reference Koot MH, Grooten IJ, Post JAMV, et al. Ketonuria is not associated with hyperemesis gravidarum disease severity. Eur J Obstet Gynecol Reprod Biol. 2020;254:315–20.PubMedCrossRef Koot MH, Grooten IJ, Post JAMV, et al. Ketonuria is not associated with hyperemesis gravidarum disease severity. Eur J Obstet Gynecol Reprod Biol. 2020;254:315–20.PubMedCrossRef
32.
go back to reference Erick M, Cox JT, Mogensen KM. ACOG Practice Bulletin 189: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2018;131:935.PubMedCrossRef Erick M, Cox JT, Mogensen KM. ACOG Practice Bulletin 189: Nausea and Vomiting of Pregnancy. Obstet Gynecol. 2018;131:935.PubMedCrossRef
33.
go back to reference Mitchell-Jones N, Gallos I, Farren J, Tobias A, Bottomley C, Bourne T. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017;124:20–30.PubMedCrossRef Mitchell-Jones N, Gallos I, Farren J, Tobias A, Bottomley C, Bourne T. Psychological morbidity associated with hyperemesis gravidarum: a systematic review and meta-analysis. BJOG. 2017;124:20–30.PubMedCrossRef
34.
35.
go back to reference Veenendaal M, van Abeelen A, Painter R, van der Post J, Roseboom T. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118:1302–13.PubMedCrossRef Veenendaal M, van Abeelen A, Painter R, van der Post J, Roseboom T. Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis. BJOG. 2011;118:1302–13.PubMedCrossRef
36.
go back to reference Vandraas K, Vikanes Å, Vangen S, Magnus P, Støer N, Grjibovski A. Hyperemesis gravidarum and birth outcomes—a population-based cohort study of 2.2 million births in the Norwegian Birth Registry. BJOG. 2013;120:1654–60.PubMedCrossRef Vandraas K, Vikanes Å, Vangen S, Magnus P, Støer N, Grjibovski A. Hyperemesis gravidarum and birth outcomes—a population-based cohort study of 2.2 million births in the Norwegian Birth Registry. BJOG. 2013;120:1654–60.PubMedCrossRef
37.
go back to reference Dodds L, Fell DB, Joseph KS, Allen VM, Butler B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006;107(2 Pt 1):285–92. Dodds L, Fell DB, Joseph KS, Allen VM, Butler B. Outcomes of pregnancies complicated by hyperemesis gravidarum. Obstet Gynecol. 2006;107(2 Pt 1):285–92.
38.
go back to reference Fiaschi L, Nelson-Piercy C, Gibson J, Szatkowski L, Tata LJ. Adverse maternal and birth outcomes in women admitted to hospital for hyperemesis gravidarum: a population-based cohort study. Paediatr Perinat Epidemiol. 2018;32:40–51.PubMedCrossRef Fiaschi L, Nelson-Piercy C, Gibson J, Szatkowski L, Tata LJ. Adverse maternal and birth outcomes in women admitted to hospital for hyperemesis gravidarum: a population-based cohort study. Paediatr Perinat Epidemiol. 2018;32:40–51.PubMedCrossRef
39.
40.
go back to reference Fejzo MS, Sazonova OV, Sathirapongsasuti JF, et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018;9:1178.PubMedPubMedCentralCrossRef Fejzo MS, Sazonova OV, Sathirapongsasuti JF, et al. Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum. Nat Commun. 2018;9:1178.PubMedPubMedCentralCrossRef
41.
go back to reference Fejzo MS, Trovik J, Grooten IJ, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5:62.PubMedCrossRef Fejzo MS, Trovik J, Grooten IJ, et al. Nausea and vomiting of pregnancy and hyperemesis gravidarum. Nat Rev Dis Primers. 2019;5:62.PubMedCrossRef
42.
go back to reference Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2018;31:2492–505.PubMedCrossRef Boelig RC, Barton SJ, Saccone G, Kelly AJ, Edwards SJ, Berghella V. Interventions for treating hyperemesis gravidarum: a Cochrane systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2018;31:2492–505.PubMedCrossRef
43.
go back to reference Thomson M, Corbin R, Leung L. Effects of ginger for nausea and vomiting in early pregnancy: a meta-analysis. J Am Board Fam Med. 2014;27:115–22.PubMedCrossRef Thomson M, Corbin R, Leung L. Effects of ginger for nausea and vomiting in early pregnancy: a meta-analysis. J Am Board Fam Med. 2014;27:115–22.PubMedCrossRef
44.
go back to reference Yamahara J, Huang Q, Li Y, Xu L, Fujimura H. Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull (Tokyo). 1990;38:430–1.PubMedCrossRef Yamahara J, Huang Q, Li Y, Xu L, Fujimura H. Gastrointestinal motility enhancing effect of ginger and its active constituents. Chem Pharm Bull (Tokyo). 1990;38:430–1.PubMedCrossRef
45.
go back to reference Backon J. Ginger in preventing nausea and vomiting of pregnancy: a caveat due to its thromboxane synthetase activity and effect on testosterone binding. Eur J Obstet Gynecol Reprod Biol. 1991;42:163-4.PubMedCrossRef Backon J. Ginger in preventing nausea and vomiting of pregnancy: a caveat due to its thromboxane synthetase activity and effect on testosterone binding. Eur J Obstet Gynecol Reprod Biol. 1991;42:163-4.PubMedCrossRef
46.
go back to reference Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;CD007575. Matthews A, Haas DM, O’Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2015;CD007575.
47.
go back to reference Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173:881–4.PubMedCrossRef Vutyavanich T, Wongtra-ngan S, Ruangsri R. Pyridoxine for nausea and vomiting of pregnancy: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 1995;173:881–4.PubMedCrossRef
48.
go back to reference Gdynia HJ, Müller T, Sperfeld AD, et al. Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord. 2008;18:156–8.PubMedCrossRef Gdynia HJ, Müller T, Sperfeld AD, et al. Severe sensorimotor neuropathy after intake of highest dosages of vitamin B6. Neuromuscul Disord. 2008;18:156–8.PubMedCrossRef
49.
go back to reference Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy. Obstet Gynecol. 2014;124:735–42.PubMedCrossRef Oliveira LG, Capp SM, You WB, Riffenburgh RH, Carstairs SD. Ondansetron compared with doxylamine and pyridoxine for treatment of nausea in pregnancy. Obstet Gynecol. 2014;124:735–42.PubMedCrossRef
52.
go back to reference Lavecchia M, Chari R, Campbell S, Ross S. Ondansetron in pregnancy and the risk of congenital malformations: a systematic review. J Obstet Gynecol Canada. 2018;40:910–8.CrossRef Lavecchia M, Chari R, Campbell S, Ross S. Ondansetron in pregnancy and the risk of congenital malformations: a systematic review. J Obstet Gynecol Canada. 2018;40:910–8.CrossRef
53.
go back to reference Kaplan YC, Richardson JL, Keskin-Arslan E, Erol-Coskun H, Kennedy D. Use of ondansetron during pregnancy and the risk of major congenital malformations: a systematic review and meta-analysis. Reprod Toxicol. 2019;86:1–13.PubMedCrossRef Kaplan YC, Richardson JL, Keskin-Arslan E, Erol-Coskun H, Kennedy D. Use of ondansetron during pregnancy and the risk of major congenital malformations: a systematic review and meta-analysis. Reprod Toxicol. 2019;86:1–13.PubMedCrossRef
54.
go back to reference Caritis S, Zhao Y, Chen HJ, Venkataramanan R. Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2016;215:93.e1-93.e4.PubMedCrossRef Caritis S, Zhao Y, Chen HJ, Venkataramanan R. Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. Am J Obstet Gynecol. 2016;215:93.e1-93.e4.PubMedCrossRef
56.
go back to reference Cape AV, Mogensen KM, Robinson MK, Carusi DA. Peripherally inserted central catheter (PICC) complications during pregnancy. JPEN J Parenter Enteral Nutr. 2014;38:595–601.PubMedCrossRef Cape AV, Mogensen KM, Robinson MK, Carusi DA. Peripherally inserted central catheter (PICC) complications during pregnancy. JPEN J Parenter Enteral Nutr. 2014;38:595–601.PubMedCrossRef
57.
go back to reference da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020;35:584–5 (published correction appears).CrossRef da Silva JSV, Seres DS, Sabino K, et al. ASPEN Consensus Recommendations for Refeeding Syndrome. Nutr Clin Pract. 2020;35:584–5 (published correction appears).CrossRef
58.
go back to reference Li L, Li L, Zhou X, Xiao S, Gu H, Zhang G. Helicobacter pylori infection is associated with an increased risk of hyperemesis gravidarum: a meta-analysis. Gastroenterol Res Pract. 2015;2015:1–13. Li L, Li L, Zhou X, Xiao S, Gu H, Zhang G. Helicobacter pylori infection is associated with an increased risk of hyperemesis gravidarum: a meta-analysis. Gastroenterol Res Pract. 2015;2015:1–13.
59.
go back to reference Koren G, Maltepe C. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol (Lahore). 2004;24:530–3.CrossRef Koren G, Maltepe C. Pre-emptive therapy for severe nausea and vomiting of pregnancy and hyperemesis gravidarum. J Obstet Gynaecol (Lahore). 2004;24:530–3.CrossRef
60.
go back to reference Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40.PubMedCrossRef Bhatia SJ, Makharia GK, Abraham P, et al. Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2019;38:411–40.PubMedCrossRef
61.
go back to reference Bhatia SJ, Abraham P. Gastro-oesophageal reflux in pregnancy: a price for the progeny. J Assoc Physicians India. 1993;41Suppl 2:8–9. Bhatia SJ, Abraham P. Gastro-oesophageal reflux in pregnancy: a price for the progeny. J Assoc Physicians India. 1993;41Suppl 2:8–9.
62.
go back to reference Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol. 2011;30:144–7.PubMedCrossRef Ramu B, Mohan P, Rajasekaran MS, Jayanthi V. Prevalence and risk factors for gastroesophageal reflux in pregnancy. Indian J Gastroenterol. 2011;30:144–7.PubMedCrossRef
63.
go back to reference Altuwaijri M. Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: a review. Medicine (Baltimore). 2022;101:e30487. Altuwaijri M. Evidence-based treatment recommendations for gastroesophageal reflux disease during pregnancy: a review. Medicine (Baltimore). 2022;101:e30487. 
64.
go back to reference Meteerattanapipat P, Phupong V. Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial. Sci Rep. 2017;7:44830.PubMedPubMedCentralCrossRef Meteerattanapipat P, Phupong V. Efficacy of alginate-based reflux suppressant and magnesium-aluminium antacid gel for treatment of heartburn in pregnancy: a randomized double-blind controlled trial. Sci Rep. 2017;7:44830.PubMedPubMedCentralCrossRef
65.
go back to reference Thélin CS, Richter JE. Review article: the management of heartburn during pregnancy and lactation. Aliment Pharmacol Ther. 2020;51:421–34.PubMedCrossRef Thélin CS, Richter JE. Review article: the management of heartburn during pregnancy and lactation. Aliment Pharmacol Ther. 2020;51:421–34.PubMedCrossRef
66.
go back to reference Kovacs GT, Campbell J, Francis D, Hill D, Adena MA. Is mucaine an appropriate medication for the relief of heartburn during pregnancy? Asia Oceania J Obstet Gynaecol. 1990;16:357–62.PubMedCrossRef Kovacs GT, Campbell J, Francis D, Hill D, Adena MA. Is mucaine an appropriate medication for the relief of heartburn during pregnancy? Asia Oceania J Obstet Gynaecol. 1990;16:357–62.PubMedCrossRef
67.
go back to reference Larson J, Patatanian E, Minerjr P, Rayburn W, Robinson M. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol. 1997;90:83–7.PubMedCrossRef Larson J, Patatanian E, Minerjr P, Rayburn W, Robinson M. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol. 1997;90:83–7.PubMedCrossRef
68.
go back to reference Dutta AK, Jain A, Jearth V, et al. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian J Gastroenterol. 2023;42:601–28.PubMedCrossRef Dutta AK, Jain A, Jearth V, et al. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian J Gastroenterol. 2023;42:601–28.PubMedCrossRef
69.
go back to reference Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363:2114–23.PubMedCrossRef Pasternak B, Hviid A. Use of proton-pump inhibitors in early pregnancy and the risk of birth defects. N Engl J Med. 2010;363:2114–23.PubMedCrossRef
70.
go back to reference Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51:410–20.PubMedCrossRef Li CM, Zhernakova A, Engstrand L, Wijmenga C, Brusselaers N. Systematic review with meta-analysis: the risks of proton pump inhibitors during pregnancy. Aliment Pharmacol Ther. 2020;51:410–20.PubMedCrossRef
72.
go back to reference Kuronen M, Hantunen S, Alanne L, et al. Pregnancy, puerperium and perinatal constipation – an observational hybrid survey on pregnant and postpartum women and their age-matched non-pregnant controls. BJOG. 2021;128:1057–64.PubMedCrossRef Kuronen M, Hantunen S, Alanne L, et al. Pregnancy, puerperium and perinatal constipation – an observational hybrid survey on pregnant and postpartum women and their age-matched non-pregnant controls. BJOG. 2021;128:1057–64.PubMedCrossRef
73.
go back to reference Rao SSC, Qureshi WA, Yan Y, Johnson DA. Constipation, hemorrhoids, and anorectal disorders in pregnancy. Am J Gastroenterol. 2022;117(10S):16–25.PubMedCrossRef Rao SSC, Qureshi WA, Yan Y, Johnson DA. Constipation, hemorrhoids, and anorectal disorders in pregnancy. Am J Gastroenterol. 2022;117(10S):16–25.PubMedCrossRef
74.
go back to reference Anderson AS, Whichelow MJ. Constipation during pregnancy: dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr. 1985;39:202–7.PubMed Anderson AS, Whichelow MJ. Constipation during pregnancy: dietary fibre intake and the effect of fibre supplementation. Hum Nutr Appl Nutr. 1985;39:202–7.PubMed
75.
go back to reference Müller M. Jaquenoud E [Treatment of constipation in pregnant women. A multicenter study in a gynecological practice]. Schweiz Med Wochenschr. 1995;125:1689–93.PubMed Müller M. Jaquenoud E [Treatment of constipation in pregnant women. A multicenter study in a gynecological practice]. Schweiz Med Wochenschr. 1995;125:1689–93.PubMed
76.
go back to reference Neri I, Blasi I, Castro P, Grandinetti G, Ricchi A, Facchinetti F. Polyethylene glycol electrolyte solution (isocolan) for constipation during pregnancy: an observational open-label study. J Midwifery Womens Health. 2004;49:355–8.PubMed Neri I, Blasi I, Castro P, Grandinetti G, Ricchi A, Facchinetti F. Polyethylene glycol electrolyte solution (isocolan) for constipation during pregnancy: an observational open-label study. J Midwifery Womens Health. 2004;49:355–8.PubMed
77.
go back to reference Li H, Zhang P, Xue Y. A comparison of the safety and efficacy of polyethylene glycol 4000 and lactulose for the treatment of constipation in pregnant women: a randomized controlled clinical study. Ann Palliat Med. 2020;9:3785–92.PubMedCrossRef Li H, Zhang P, Xue Y. A comparison of the safety and efficacy of polyethylene glycol 4000 and lactulose for the treatment of constipation in pregnant women: a randomized controlled clinical study. Ann Palliat Med. 2020;9:3785–92.PubMedCrossRef
78.
go back to reference Greenhalf JO, Leonard HS. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers. Practitioner. 1973;210:259–63.PubMed Greenhalf JO, Leonard HS. Laxatives in the treatment of constipation in pregnant and breast-feeding mothers. Practitioner. 1973;210:259–63.PubMed
79.
go back to reference Menees SB, Lembo A, Charabaty A. Fecal incontinence and diarrhea during pregnancy. Am J Gastroenterol. 2022;117(10S):26–32. Menees SB, Lembo A, Charabaty A. Fecal incontinence and diarrhea during pregnancy. Am J Gastroenterol. 2022;117(10S):26–32.
80.
go back to reference Roy P, Deb N. Racecadotril versus loperamide for the treatment of acute diarrhoea. Egypt J Intern Med. 2023;35:32.CrossRef Roy P, Deb N. Racecadotril versus loperamide for the treatment of acute diarrhoea. Egypt J Intern Med. 2023;35:32.CrossRef
81.
go back to reference Meyer A, Fermaut M, Drouin J, Carbonnel F, Weill A. Drug use for gastrointestinal symptoms during pregnancy: a French nationwide study 2010–2018. PLoS One. 2021;16:e0245854. Meyer A, Fermaut M, Drouin J, Carbonnel F, Weill A. Drug use for gastrointestinal symptoms during pregnancy: a French nationwide study 2010–2018. PLoS One. 2021;16:e0245854.
82.
go back to reference Jarde A, Lewis-Mikhael AM, Moayyedi P, et al. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18:14.PubMedPubMedCentralCrossRef Jarde A, Lewis-Mikhael AM, Moayyedi P, et al. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018;18:14.PubMedPubMedCentralCrossRef
83.
go back to reference Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet Gynecol. 2014;124:1241–4. Committee Opinion No. 614: Management of pregnant women with presumptive exposure to Listeria monocytogenes. Obstet Gynecol. 2014;124:1241–4.
84.
go back to reference Poskus T, Buzinskienė D, Drasutiene G, et al. Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. BJOG. 2014;121:1666–71.PubMedCrossRef Poskus T, Buzinskienė D, Drasutiene G, et al. Haemorrhoids and anal fissures during pregnancy and after childbirth: a prospective cohort study. BJOG. 2014;121:1666–71.PubMedCrossRef
85.
go back to reference Iyer VS, Shrier I, Gordon PH. Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum. 2004;47:1364–70.PubMedCrossRef Iyer VS, Shrier I, Gordon PH. Long-term outcome of rubber band ligation for symptomatic primary and recurrent internal hemorrhoids. Dis Colon Rectum. 2004;47:1364–70.PubMedCrossRef
86.
go back to reference Porwal A, Gandhi P, Kulkarni D. Laser hemorrhoidopexy: an observational study of 1088 patients treated at single center. Indian J Colo-Rectal Surgery. 2022;5:61–7.CrossRef Porwal A, Gandhi P, Kulkarni D. Laser hemorrhoidopexy: an observational study of 1088 patients treated at single center. Indian J Colo-Rectal Surgery. 2022;5:61–7.CrossRef
87.
go back to reference Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: Report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–8.PubMed Ghoshal UC, Abraham P, Bhatt C, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: Report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–8.PubMed
88.
go back to reference Khashan AS, Quigley EMM, McNamee R, McCarthy FP, Shanahan F, Kenny LC. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012;10:902–9.PubMedCrossRef Khashan AS, Quigley EMM, McNamee R, McCarthy FP, Shanahan F, Kenny LC. Increased risk of miscarriage and ectopic pregnancy among women with irritable bowel syndrome. Clin Gastroenterol Hepatol. 2012;10:902–9.PubMedCrossRef
89.
go back to reference Moosavi S, Pimentel M, Wong MS, Rezaie A. Irritable bowel syndrome in pregnancy. Am J Gastroenterol. 2021;116:480–90.PubMedCrossRef Moosavi S, Pimentel M, Wong MS, Rezaie A. Irritable bowel syndrome in pregnancy. Am J Gastroenterol. 2021;116:480–90.PubMedCrossRef
91.
92.
go back to reference Sethi A, Banerjee S, Chahal P. Advanced endoscopic procedures in pregnancy. Am J Gastroenterol. 2022;117(10S):39–43.PubMedCrossRef Sethi A, Banerjee S, Chahal P. Advanced endoscopic procedures in pregnancy. Am J Gastroenterol. 2022;117(10S):39–43.PubMedCrossRef
93.
go back to reference Pal P, Reddy DN, Tandan M. Endoscopy in pregnancy: a systematic review. J Digest Endosc. 2021;12:138–50.CrossRef Pal P, Reddy DN, Tandan M. Endoscopy in pregnancy: a systematic review. J Digest Endosc. 2021;12:138–50.CrossRef
95.
go back to reference Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Womens Dermatol. 2017;3:6–10.PubMedPubMedCentralCrossRef Trivedi MK, Kroumpouzos G, Murase JE. A review of the safety of cosmetic procedures during pregnancy and lactation. Int J Womens Dermatol. 2017;3:6–10.PubMedPubMedCentralCrossRef
96.
go back to reference Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG. 2000;107:792–4.PubMedCrossRef Bortolus R, Ricci E, Chatenoud L, Parazzini F. Nifedipine administered in pregnancy: effect on the development of children at 18 months. BJOG. 2000;107:792–4.PubMedCrossRef
97.
go back to reference Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled, multicentre study of loperimide in pregnancy. Can J Gastroenterol. 2000;14:185–7.PubMedCrossRef Einarson A, Mastroiacovo P, Arnon J, et al. Prospective, controlled, multicentre study of loperimide in pregnancy. Can J Gastroenterol. 2000;14:185–7.PubMedCrossRef
98.
go back to reference Källén B, Nilsson E, Olausson PO. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr. 2008;97:541–5.PubMedCrossRef Källén B, Nilsson E, Olausson PO. Maternal use of loperamide in early pregnancy and delivery outcome. Acta Paediatr. 2008;97:541–5.PubMedCrossRef
99.
go back to reference Zhang R, Persaud N. 8-Way randomized controlled trial of doxylamine, pyridoxine and dicyclomine for nausea and vomiting during pregnancy: restoration of unpublished information. PLoS One. 2017;12: e0167609.PubMedPubMedCentralCrossRef Zhang R, Persaud N. 8-Way randomized controlled trial of doxylamine, pyridoxine and dicyclomine for nausea and vomiting during pregnancy: restoration of unpublished information. PLoS One. 2017;12: e0167609.PubMedPubMedCentralCrossRef
Metadata
Title
Gastrointestinal symptoms and disorders of gut-brain interaction in pregnancy
Authors
Abhinav Jain
Shraddha Ramchandani
Shobna Bhatia
Publication date
04-01-2025
Publisher
Springer India
Published in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-024-01705-z

Keynote webinar | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.   

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Watch now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more